May Kung Sutherland

1.6k total citations
33 papers, 1.2k citations indexed

About

May Kung Sutherland is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, May Kung Sutherland has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Genetics. Recurrent topics in May Kung Sutherland's work include Estrogen and related hormone effects (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Bone Metabolism and Diseases (5 papers). May Kung Sutherland is often cited by papers focused on Estrogen and related hormone effects (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Bone Metabolism and Diseases (5 papers). May Kung Sutherland collaborates with scholars based in United States, Canada and Switzerland. May Kung Sutherland's co-authors include Changpu Yu, James C. Geoghegan, John Latham, David G. Winkler, D. R. Crapper McLachlan, Martin J. Somerville, John E. Skonier, Catherine Bergeron, Eileen Turcott and Mark R. Haussler and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

May Kung Sutherland

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
May Kung Sutherland United States 18 551 520 202 176 149 33 1.2k
Joseph J. Pinzone United States 17 696 1.3× 506 1.0× 89 0.4× 152 0.9× 70 0.5× 24 1.5k
Patrick Mollat France 16 1.0k 1.8× 476 0.9× 62 0.3× 228 1.3× 133 0.9× 34 1.5k
Su Jane Rutledge United States 18 1.1k 1.9× 470 0.9× 75 0.4× 216 1.2× 86 0.6× 19 1.6k
F. van Valen Germany 22 844 1.5× 491 0.9× 114 0.6× 103 0.6× 272 1.8× 47 1.5k
Andrew Sunters United Kingdom 23 1.4k 2.6× 612 1.2× 190 0.9× 466 2.6× 74 0.5× 36 2.1k
Elizabeth Allan Australia 24 1.1k 2.0× 658 1.3× 48 0.2× 131 0.7× 178 1.2× 40 1.7k
Carolyn Lowe New Zealand 14 948 1.7× 614 1.2× 32 0.2× 89 0.5× 162 1.1× 23 1.5k
Olga A. Agapova United States 23 914 1.7× 232 0.4× 143 0.7× 159 0.9× 155 1.0× 29 1.8k
Nader Chalhoub United States 11 1.2k 2.2× 347 0.7× 114 0.6× 138 0.8× 103 0.7× 18 1.5k
Dorothy Hu United States 16 801 1.5× 366 0.7× 56 0.3× 180 1.0× 82 0.6× 26 1.2k

Countries citing papers authored by May Kung Sutherland

Since Specialization
Citations

This map shows the geographic impact of May Kung Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Kung Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Kung Sutherland more than expected).

Fields of papers citing papers by May Kung Sutherland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May Kung Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Kung Sutherland. The network helps show where May Kung Sutherland may publish in the future.

Co-authorship network of co-authors of May Kung Sutherland

This figure shows the co-authorship network connecting the top 25 collaborators of May Kung Sutherland. A scholar is included among the top collaborators of May Kung Sutherland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with May Kung Sutherland. May Kung Sutherland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Banks, Matthew I., Elie Matar, May Kung Sutherland, et al.. (2025). Clinical and intracranial electrophysiological signatures of post-operative and post-ictal delirium. Clinical Neurophysiology. 171. 38–50. 3 indexed citations
2.
Gardai, Shyra J., Angela Epp, Lori Westendorf, et al.. (2015). Abstract 2472: SEA-CD40, a sugar engineered non-fucosylated anti-CD40 antibody with improved immune activating capabilities. Cancer Research. 75(15_Supplement). 2472–2472. 5 indexed citations
3.
4.
Sutherland, May Kung, Changpu Yu, Martha E. Anderson, et al.. (2010). 5-Azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia. mAbs. 2(4). 440–448. 24 indexed citations
5.
Ryan, Maureen C., Heather Kostner, Karen A. Gordon, et al.. (2010). Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75. British Journal of Cancer. 103(5). 676–684. 68 indexed citations
6.
Sutherland, May Kung, Changpu Yu, Timothy S. Lewis, et al.. (2009). Anti-leukemic activity of Lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia. mAbs. 1(5). 481–490. 32 indexed citations
7.
Smith, Leia M., Albina Nesterova, Maureen C. Ryan, et al.. (2008). CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. British Journal of Cancer. 99(1). 100–109. 218 indexed citations
8.
Lewis, Timothy S., Jamie B. Miyamoto, May Kung Sutherland, et al.. (2007). The humanized anti-CD40 monoclonal antibody, SGN-40, signals apoptosis in non-Hodgkin's lymphoma by dual mechanisms. Molecular Cancer Therapeutics. 6. 1 indexed citations
9.
Rao, L.G., Timothy M. Murray, John N. Wylie, Robert McBroom, & May Kung Sutherland. (2005). Long-term culture in dexamethasone unmasks an abnormal phenotype in osteoblasts isolated from osteoporotic subjects. Journal of Endocrinological Investigation. 28(1). 919–927. 2 indexed citations
10.
Winkler, David G., Changpu Yu, James C. Geoghegan, et al.. (2004). Noggin and Sclerostin Bone Morphogenetic Protein Antagonists Form a Mutually Inhibitory Complex. Journal of Biological Chemistry. 279(35). 36293–36298. 82 indexed citations
11.
McKie, Jeffrey A., Shripad S. Bhagwat, Helen Brady, et al.. (2004). Lead identification of a potent benzopyranone selective estrogen receptor modulator. Bioorganic & Medicinal Chemistry Letters. 14(13). 3407–3410. 33 indexed citations
12.
Sutherland, May Kung, James C. Geoghegan, Changpu Yu, et al.. (2004). Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation. Bone. 35(4). 828–835. 180 indexed citations
13.
Brady, Helen, Matthew Hickman, Normand Richard, et al.. (2002). Differential Response of Estrogen Receptors α and β to SP500263, a Novel Potent Selective Estrogen Receptor Modulator. Molecular Pharmacology. 61(3). 562–568. 29 indexed citations
14.
Sutherland, May Kung, Dini Hui, L.G. Rao, John N. Wylie, & Timothy M. Murray. (1996). Immunohistochemical localization of the estrogen receptor in human osteoblastic SaOS-2 cells: Association of receptor levels with alkaline phosphatase activity. Bone. 18(4). 361–369. 31 indexed citations
15.
16.
Sutherland, May Kung, L.G. Rao, John N. Wylie, et al.. (1994). Carboxyl-terminal parathyroid hormone peptide (53–84) elevates alkaline phosphatase and osteocalcin mRNA levels in SaOS-2 cells. Journal of Bone and Mineral Research. 9(4). 453–458. 36 indexed citations
17.
Sutherland, May Kung, L. Wong, Martin J. Somerville, et al.. (1993). Reduction of calbindin-28k mRNA levels in Alzheimer as compared to Huntington hippocampus. Molecular Brain Research. 18(1-2). 32–42. 36 indexed citations
18.
Sutherland, May Kung, L. Wong, Martin J. Somerville, et al.. (1992). Reduction of thyroid hormone receptor c-ERB Aα mRNA levels in the hippocampus of Alzheimer as compared to huntington brain. Neurobiology of Aging. 13(2). 301–312. 27 indexed citations
19.
McLachlan, D. R. Crapper, Walter J. Lukiw, Craig A. Mizzen, et al.. (1991). Anomalous Gene Expression in Alzheimer Disease: Cause or Effect. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 18(S3). 414–418. 4 indexed citations
20.
Lukiw, Walter J., Patricia Handley, May Kung Sutherland, L. Wong, & D. R. Crapper McLachlan. (1991). A Correlation Between Gene Transcriptional Activity and Cerebral Glucose Metabolism in Alzheimer’s Disease-Affected Neocortex: Cause or Effect?. Advances in experimental medicine and biology. 291. 249–256. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph J. Pinzone Breakdown of academic impact, for papers by Patrick Mollat Breakdown of academic impact, for papers by Su Jane Rutledge Breakdown of academic impact, for papers by F. van Valen Breakdown of academic impact, for papers by Andrew Sunters Breakdown of academic impact, for papers by Elizabeth Allan Breakdown of academic impact, for papers by Carolyn Lowe Breakdown of academic impact, for papers by Olga A. Agapova Breakdown of academic impact, for papers by Nader Chalhoub Breakdown of academic impact, for papers by Dorothy Hu
Rankless by CCL
2026